H1 Blog

JULY 30, 2024

This crucial inclusion of diverse populations through enrollment accuracy creates a direct correlation to operational efficiency, allowing for a quicker go-to-market process, a reduction in costly mistakes, and a more robust alignment to overall FDA requirements. Find out more by requesting a demo today.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

H1 Blog

JUNE 7, 2023

Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data will be invaluable in identifying potential contacts for marketing efforts, allowing the Foundation to effectively reach out to physicians who are most likely to be interested in their initiatives.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

H1 Blog

DECEMBER 11, 2024

While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. Furthermore, as pharma looks to offset future price controls, the prices of new drugs will likely spike.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

JULY 5, 2023

From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. To learn more about how H1 can help diversify your HCP engagement strategy, request a demo.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52